Atlas Trials

Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US (PULSAR).

Clinical trial NCT02173990 · TERMINATED

Trial details

NCT number
NCT02173990
Sponsor
Centre Oscar Lambret
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2014-07-01
Primary completion
2018-11-02
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.